Vaidya Sane Ayurved Laboratories Limited

Medical/Nursing Services/ NSE

Compiled

Auto-generated from filings and public channels — no analyst dossier.

If management delivers what it guided

arithmetic on filed guidance and past valuations · not a price target

MADHAVBAUG

FY26 → FY27 · 1 year of guidance · ~0.7 years from today₹194 today

BEAR

₹136

-30%

2.9% a year · 15.4x exit

BASE

₹255

+32%

5% a year · 28.4x exit

BULL

₹726

+275%

6.8% a year · 79.5x exit

Where the market has priced it

14x23x today100x

management named no year; shown one year out

the guided figure reached earnings through a low-confidence bridge
multiple band rests on only 4 filed years
the last 3 years priced this company 32% below its ten-year median (19x vs 28x) — the exit multiple here is the ten-year one, so a sustained re-rating would not be captured
the range is unusually wide — read it as the span of management's own claim, not as a forecast
this company's own median multiple sits 34% below its filed-industry peers; the scenario uses its own

How these numbers are produced

Earnings base	FY26 fiscal year EPS ₹8.55 (screener)
Guided growth	5% a year, said on the call of 20-May-2026 · transcript
Read across as	operating: unlabelled growth figure, read as revenue — low confidence
Delivery calibration	0.58x / 1x / 1.36x of what was guided — measured: 76 annual guided-vs-filed pairs + 77 near-complete quarterly years — NSE transcripts against the companies' own filings
Exit multiple	15.45x / 28.45x / 79.55x, this company’s own p20 / median / p80 across 4 filed years
Filed-industry peers	median 43.2x across 6 peers — the cross-check, not the input
Arithmetic	base EPS × (1 + guided growth × delivery)¹ × exit multiple

Arithmetic on management’s own guidance and this company’s own past valuations. Not a price target, not a recommendation, and not a forecast of what the stock will do.

How to read this

It answers one question. If this management delivers the growth it told its own investors it would, and the market pays what it has historically paid for this company's earnings, where does the arithmetic land? Nothing here is a forecast of the share price.
Three cases, two moving parts. Bear, base and bull vary the delivery — what fraction of guidance managements actually file — and the exit multiple together, because a company that misses its guidance is usually de-rated for missing it. Each case shows the growth rate and the multiple that produced it.
Read the width, not just the middle. A wide gap between bear and bull means the inputs are uncertain, not that the upside is bigger. A narrow range is a more confident statement than a high one.
“Where the market has priced it” puts today's P/E on the company's own historical range. Sitting far below that range is why a scenario can look enormous: the number is then mostly about re-rating, not about delivery, and the board marks those separately.
The bullets underneath are the caveats — a borrowed peer multiple, a thin filed history, an earnings base that carried a one-off. They are the reasons to trust the number less, listed rather than buried.

Not a price target, not a recommendation, and not a forecast of what the stock will do. The field guide covers the method.

What management said

from NSE earnings-call filings · extracted, not interpreted

generic growth 5%

Rohit Madhav Sane: Yes, we will be seeing a single digit ARPU growth also, as well as the number of beds also should increase to a marginal level.

Call 20-May-2026 · bridge confidence low · transcript PDF